Effect of the peer mentoring program on the therapeutic communication skills of students taking pediatric nursing courses.

J Pediatr NursJun 26, 2026 (epub)
Clinical ResearchPediatrics

Rukiye Celik, Şerefnaz Güner, Ayşenur Ağcinlioğlu

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the impact of a peer mentoring program on the therapeutic communication skills of 84 third-year nursing students in a pediatric nursing course. Results indicated that students in the peer mentoring group showed significantly greater improvements in therapeutic communication skills compared to the control group, particularly in total test scores and Therapeutic Communication Skills 1.

Key findings

  • Students in the peer mentoring group showed significantly greater improvements in total test scores compared to the control group.
  • Significant time and group × time interaction effects were observed in Therapeutic Communication Skills 1.
  • Material Evaluation Checklist scores were significantly higher in the intervention group (p < 0.001).

Why it matters

Enhancing therapeutic communication skills is crucial for nurses working with pediatric patients, as it fosters effective and developmentally appropriate interactions. This study suggests that peer mentoring can be an effective educational strategy to improve these skills.

Source

Published in J Pediatr Nurs. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.